24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo

This publication has 107 references indexed in Scilit:

• The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy
  Chemotherapy Research and Practice, 2012
• Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
  BMC Bioinformatics, 2012
• Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)
  Journal of Biological Chemistry, 2012
• The Influence of Health and Lifestyle Characteristics on the Relation of Serum 25-Hydroxyvitamin D With Risk of Colorectal and Breast Cancer in Postmenopausal Women
  American Journal of Epidemiology, 2012
• DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors
  Molecular Biology of the Cell, 2012
• CYP24A1Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma
  Clinical Cancer Research, 2011
• Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down
  BMC Genomics, 2009
• Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer
  JNCI: Journal of the National Cancer Institute, 2008
• Characterization of methyl-β-cyclodextrin toxicity in NGF-differentiated PC12 cell death
  NeuroToxicology, 2007
• 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1996